Brief: Avadel Board Of Directors Declares Lundbeck Proposal A “Company Superior Proposal”
Alkermes Plc ALKS.O: AVADEL BOARD OF DIRECTORS DECLARES LUNDBECK PROPOSAL A “COMPANY SUPERIOR PROPOSAL” AVADEL PHARMACEUTICALS: PURSUANT TO ALKERMES DEAL, CO & ALKERMES MAY NEGOTIATE POTENTIAL ADJUSTMENTS TO EXISTING TRANSACTION FOR 5 BUSINESS DAYS Source text: ID:nGNXbLZ1hS Further company coverage: ALKS.O
Recent news on H Lundbeck A/S
See all newsUBS upgrades Lundbeck to 'buy' on high epilepsy drug conviction
DB downgrades Lundbeck to 'sell' on Rexulti patent cliff risk
Europe Research Roundup: ASM International, Michelin, Nokian Renkaat
Europe Research Roundup: BAWAG Group, Enka Insaat, Partners Group Holding
Brief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program